USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS Read more about USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US Patent 11,702,472Filed on 2020-03-17
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY US Application 16/760,138Filed on 2020-04-29
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY South Korea10-2020-7016052Filed on 2020-06-04
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Japan2020-524774Filed on 2018-11-06
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY European Patent18819232.2Filed on 2020-05-07
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY China201880071646.5Filed on 2018-11-06
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Canada3081757Filed on 2018-11-06
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY Australia2018360784Filed on 2020-05-01
MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE Read more about MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US Patent 11,014,902Filed on 2020-03-30
Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation Read more about Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation European Patent20212578.7Filed on 2020-12-08